Boston Bio Systems Limited has announced a board meeting to consider the financial results for the quarter and half-year.

The company has submitted a compliance certificate confirming that all securities dematerialized or rematerialized during the quarter have been processed and updated in the register of members within the stipulated time.

This ensures smooth transfer and accurate ownership records, reflecting good governance and operational efficiency important for shareholders and market participants.